Literature DB >> 9311801

Importance of the cysteine-rich carboxyl-terminal half of V protein for Sendai virus pathogenesis.

A Kato1, K Kiyotani, Y Sakai, T Yoshida, T Shioda, Y Nagai.   

Abstract

The Sendai virus V protein is a nonstructural trans-frame protein whose cysteine-rich C-terminal half is fused to the acidic N-terminal half of the P protein via mRNA editing. We recently created a mutant by disrupting the editing motif, which is devoid of mRNA editing and hence unable to produce the V protein, and demonstrated that this V(-) virus replicated normally or even faster with augmented gene expression and cytopathogenicity in cells in vitro, but was strongly attenuated in pathogenicity for mice (A. Kato, K. Kiyotani, Y. Sakai, T. Yoshida, and Y. Nagai, EMBO J. 16:578-587, 1997). Thus, although categorized as a nonessential protein, the V protein appeared to encode a luxury function required for the viral in vivo pathogenesis. Here, we created another version of a V-deficient mutant, VdeltaC, encoding only the N-terminal half but not the V-specific C-terminal half, by introducing a stop codon in the trans-V frame, and then we compared its in vitro and in vivo phenotypes with those of the V(-) and wild-type viruses. The VdeltaC virus was found to be similar to the wild-type virus in vitro with no augmented gene expression and cytopathogenicity, but in vivo, it resembled the V(-) virus, displaying a similarly attenuated phenotype. Thus, the pathogenicity determinant in the V protein was mapped to the C-terminal half. The N-terminal half was likely sufficient to confer normal (wild-type) in vitro phenotypes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9311801      PMCID: PMC192068          DOI: 10.1128/JVI.71.10.7266-7272.1997

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

1.  The paramyxovirus SV5 V protein binds two atoms of zinc and is a structural component of virions.

Authors:  R G Paterson; G P Leser; M A Shaughnessy; R A Lamb
Journal:  Virology       Date:  1995-04-01       Impact factor: 3.616

2.  Editing of the Sendai virus P/C mRNA by G insertion occurs during mRNA synthesis via a virus-encoded activity.

Authors:  S Vidal; J Curran; D Kolakofsky
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

3.  Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase.

Authors:  T R Fuerst; E G Niles; F W Studier; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

4.  Innate cytotoxicity of CBA mouse spleen cells to Sendai virus-infected L cells.

Authors:  M J Anderson
Journal:  Infect Immun       Date:  1978-06       Impact factor: 3.441

5.  Initiation of Sendai virus multiplication from transfected cDNA or RNA with negative or positive sense.

Authors:  A Kato; Y Sakai; T Shioda; T Kondo; M Nakanishi; Y Nagai
Journal:  Genes Cells       Date:  1996-06       Impact factor: 1.891

6.  Sequence of 3,687 nucleotides from the 3' end of Sendai virus genome RNA and the predicted amino acid sequences of viral NP, P and C proteins.

Authors:  T Shioda; Y Hidaka; T Kanda; H Shibuta; A Nomoto; K Iwasaki
Journal:  Nucleic Acids Res       Date:  1983-11-11       Impact factor: 16.971

7.  Transcriptive complex of Newcastle disease virus. I. Both L and P proteins are required to constitute an active complex.

Authors:  M Hamaguchi; T Yoshida; K Nishikawa; H Naruse; Y Nagai
Journal:  Virology       Date:  1983-07-15       Impact factor: 3.616

8.  The role of interferon in the NK cell killing of virus-infected target cells.

Authors:  M J Anderson
Journal:  J Hyg (Lond)       Date:  1982-10

9.  Ribosomal initiation from an ACG codon in the Sendai virus P/C mRNA.

Authors:  J Curran; D Kolakofsky
Journal:  EMBO J       Date:  1988-01       Impact factor: 11.598

10.  Two mRNAs that differ by two nontemplated nucleotides encode the amino coterminal proteins P and V of the paramyxovirus SV5.

Authors:  S M Thomas; R A Lamb; R G Paterson
Journal:  Cell       Date:  1988-09-09       Impact factor: 41.582

View more
  37 in total

1.  The versatility of paramyxovirus RNA polymerase stuttering.

Authors:  S Hausmann; D Garcin; C Delenda; D Kolakofsky
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

2.  Comparison of predicted amino acid sequences of measles virus strains in the Edmonston vaccine lineage.

Authors:  C L Parks; R A Lerch; P Walpita; H P Wang; M S Sidhu; S A Udem
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

3.  Conserved and non-conserved regions in the Sendai virus genome: evolution of a gene possessing overlapping reading frames.

Authors:  Y Fujii; K Kiyotani; T Yoshida; T Sakaguchi
Journal:  Virus Genes       Date:  2001-01       Impact factor: 2.332

4.  Involvement of the zinc-binding capacity of Sendai virus V protein in viral pathogenesis.

Authors:  C Huang; K Kiyotani; Y Fujii; N Fukuhara; A Kato; Y Nagai; T Yoshida; T Sakaguchi
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

5.  Respiratory syncytial virus that lacks open reading frame 2 of the M2 gene (M2-2) has altered growth characteristics and is attenuated in rodents.

Authors:  H Jin; X Cheng; H Z Zhou; S Li; A Seddiqui
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

6.  Inhibition of interferon regulatory factor 3 activation by paramyxovirus V protein.

Authors:  Takashi Irie; Katsuhiro Kiyotani; Tomoki Igarashi; Asuka Yoshida; Takemasa Sakaguchi
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

Review 7.  The regulation of type I interferon production by paramyxoviruses.

Authors:  Stephen Goodbourn; Richard E Randall
Journal:  J Interferon Cytokine Res       Date:  2009-09       Impact factor: 2.607

8.  Versatility of the accessory C proteins of Sendai virus: contribution to virus assembly as an additional role.

Authors:  M K Hasan; A Kato; M Muranaka; R Yamaguchi; Y Sakai; I Hatano; M Tashiro; Y Nagai
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

9.  A novel P/V/C gene in a new member of the Paramyxoviridae family, which causes lethal infection in humans, horses, and other animals.

Authors:  L F Wang; W P Michalski; M Yu; L I Pritchard; G Crameri; B Shiell; B T Eaton
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

10.  Complete genome sequence and biological characterizations of a novel goose paramyxovirus-SF02 isolated in China.

Authors:  Jian Zou; Songhua Shan; Nengtao Yao; Zuxun Gong
Journal:  Virus Genes       Date:  2005-01       Impact factor: 2.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.